Governance

THE OBSERVATIONAL MEDICAL OUTCOMES PARTNERSHIP EXECUTIVE BOARD:

    Executive Board Chairperson
    Janet Woodcock, MD
    Director, Center for Drug Evaluation and Research, Food and Drug Administration

    Executive Board Members:
    Rebecca Burkholder
    Vice-President Health Policy, The National Consumers League

    Sherine E. Gabriel MD MSc.
    William J. and Charles H. Mayo Professor, Professor of Medicine and Epidemiology, The Mayo Clinic

    Cynthia Gilman, JD
    Special Assistant to the President for Advancement of Cancer Research and Collaborative Partnerships, Henry Jackson Foundation

    Jesse L. Goodman, MD, MPH
    Chief Scientist and Deputy Commissioner (Acting) for Science and Public Health, Food and Drug Administration

    Ronald L. Krall, MD
    Former Senior Vice-President and Chief Medical Officer, GlaxoSmithKline

    Richard Platt, MD, MSc.
    Professor and Chair of the Department of Ambulatory Care and Prevention, Harvard Medical School and Harvard Pilgrim Health Care

    Stephen Spielberg, MD, PhD
    Marion Merrell Dow Chair in Pediatric Pharmocogenomics, Children’s Mercy Hospital and Dean Emeritus, Dartmouth Medical School

    Brian L. Strom, MD, MPH
    George S. Pepper Professor of Public Health and Preventive Medicine
    Professor of Biostatistics and Epidemiology, Medicine, and Pharmacology
    Chair, Department of Biostatistics and Epidemiology
    Director, Center for Clinical Epidemiology and Biostatistics
    Vice Dean for Institutional Affairs, University of Pennsylvania School of Medicine
    Senior Advisor to the Provost for Global Health Initiatives, University of Pennsylvania

    David Wheadon, MD
    Senior Vice-President, Pharmaceutical Research and Manufacturers of America (PhRMA)

    SCIENTIFIC ADVISORY BOARD:
    The Scientific Advisory Board (SAB) provides independent review of and expert input into the scientific aspects of OMOP’s activities. The SAB includes qualified scientists from academia, government, payers, providers, industry; and consumer representation.

    Elizabeth B. Andrews, MPH, PhD
    Vice President, Pharmacoepidemiology and Risk Management, RTI Health Solutions; Adjunct Associate Professor, UNC-CH Schools of Public Health and Pharmacy

    Andrew Bate, PhD
    Pfizer, Senior Director, Quantitative Epidemiologist

    Dr. Jesse Berlin
    Johnson & Johnson Pharmaceutical R & D, Vice President, Epidemiology

    Robert Lowell Davis, MD, MPH
    Center for Health Research Southeast; Kaiser Permanente Georgia, Director of Research

    Steven D. Findlay
    Consumers Union, Senior Health Policy Analyst

    Sean Hennessy, PharmD, PhD
    Assistant Professor of Epidemiology and of Pharmacology, University of Pennsylvania School of Medicine

    Michael S. Katz
    International Myeloma Foundation; Coalition of Cancer Cooperative Groups, Vice President; Chair, Patient Advisory Board

    Allen A. Mitchell, MD
    Professor of Epidemiology & Pediatrics, Boston University Schools of Public Health & Medicine, Director, Slone Epidemiology Center at Boston University

    Dr. David Page
    University of Wisconsin – Madison, Professor, Department of Biostatistics & Medical Informatics

    Kenneth J. Rothman, DrPH
    RTI Health Solutions, RTI International, Research Triangle Park, NC, Distinguished Fellow and Vice President, Epidemiology Research; Boston University, Boston, MA, Professor of Epidemiology and Medicine

    Judy A. Staffa, PhD, R.Ph
    FDA/CDER/OSE, Associate Director for Regulatory Research

    Alexander M. Walker, MD, DrPH
    World Health Information Science Consultants, LLC, Wellesley, MA, Principal;
    Department of Epidemiology Harvard School of Public Health, Boston, MA, Adjunct Professor

    HEALTH INFORMATICS ADVISORY BOARD:
    The Health Informatics Advisory Board (HIAB) provides independent review and expert input into the OMOP’s technology efforts related to privacy and security, terminology and coding, data, and data models. The HIAB includes qualified experts from academia, government, payers, providers, industry, privacy, and technology companies.

    Col. Kevin Abbott, MD, MPH
    Staff Nephrologist, Washington, DC

    Jeffrey S. Brown, PhD
    Harvard Medical School; Harvard Pilgrim Health Care; Department of Ambulatory Care and Prevention, Lecturer; Director of the HMORN CERT Data Coordinating Center; Research Director, Therapeutics Research and Infectious Disease Epidemiology

    Stanley M. Huff, MD
    Intermountain Healthcare; University of Utah School of Medicine, Chief Medical Informatics Officer; Professor (clinical)

    Diane T. MacKinnon
    FDA (CDER), Patient Consultant

    Kenneth D. Mandl, MD, MPH
    Associate Professor, Harvard Medical School
    Director, Intelligent Health Laboratory, Children’s Hospital Informatics Program, Children’s Hospital Boston

    Dr. Clement J. McDonald
    Director, Lister Hill Center for Biomedical Communications

    David S. Memel, MD, MS, MBA
    Chief Medical Officer and SVP of Analytics
    LifeCare, Inc.

    Mitra Rocca
    Associate Director, Medical Informatics
    Food and Drug Administration

    Robert Thwaites
    United BioSource Corporation, Senior Executive Director - Europe